
Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic
Published on May 11, 2026
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.

Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.